Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Model Informed Drug Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Model Informed Drug Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Model Informed Drug Development Today - Breaking & Trending Today
Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
/PRNewswire/ -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of Ann...
Source: prnewswire.com
Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
/PRNewswire/ -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of Ann...
Source: prnewswire.com
Japan's Pharmaceuticals and Medical Devices Agency (PMDA)
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions The PMDA enters 8th consecutive year of using Certara’s biosimulation software June 23, 2021 19:00 ET | Source: Certara Certara Princeton, New Jersey, UNITED STATES PRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of Certara’s Simcyp™ and Ph...
Source: globenewswire.com